Intravitreal (IVT) drug products assume a pivotal role in treating retinal disease often used to prevent or reverse damage that could lead to blindness. The production of these drugs present unique challenges and involve specific requirements.
Join our webinar as we dive into the unique aspects of manufacturing IVT drugs, explore strategies to minimize volume loss during the fill-finish process and provide insights on choosing a Contract Manufacturing Organization (CMO) tailored to your requirements. Additionally, we address the complexities of dispensing consistently small volume fills and offer solutions to mitigate endotoxin and particle counts in drug products.